Skip to main content

Keynote Talk - Translational Potential of Non-coding RNAs in Oncology

Abstract:

For many years, the central dogma of molecular biology has been that RNA functions mainly as an informational intermediate between DNA sequence and its encoded protein. One of the great surprises of modern biology was the discovery that protein-coding genes represent less than 2% of the total genome sequence, and subsequently that almost 90% of the human genome is actively transcribed. Thus, human transcriptome was found to be more complex than a collection of protein-coding gene transcripts and their splice variants. Recent evidence has clearly shown that non-coding RNAs (ncRNAs) play major biological roles in cellular development, physiology and pathologies. ncRNAs are grouped into two major classes based on transcript size; small ncRNAs and long ncRNAs. Each of these classes can be further divided, whereas novel subclasses are still being discovered and characterized. In the last ten years, class of small ncRNAs called microRNAs was studied most intensively with more than fifty thousand hits at PubMed database. A huge amount of evidence has been accumulated to describe molecular mechanisms of novel RNA species functioning, providing insight into their functional roles in cellular biology and in human disease, especially in cancer. Knowledge regarding ncRNAs functioning in cancer biology and their translational potential to serve as disease biomarkers and novel therapeutic targets in cancer will be summarized and demonstrated on several examples based on our recent observations.

Speaker Biography: 
Ondrej Slaby is a Professor of Medical Biochemistry at the 1st Faculty of Medicine at Charles University in Prague, Czech Republic. He works as Research Group Leader at the Department of Molecular Medicine, Central European Institute of Technology (CEITEC), Masaryk University (Brno, Czech Republic) and as a Scientific Secretary at the Masaryk Memorial Cancer Institute in Brno. Prof. Slaby has published extensively in the field of non-coding RNAs and solid cancer with special focus on their translational potential in diagnostics and as the therapeutic targets (h-index 31, Sum of the times cited without auto-citations > 3500. Since 2018, prof. Slaby is a chair of Czechoslovak Biological Society. In 2010 and 2012 received Award of Czech Society for Oncology, in 2016 an Award of Czech Medical Society and 2014 and 2016 Award for Medical Research of Czech Minister of Health, Novartis Discovery Award 2017.

Comments

Post a Comment

Popular posts from this blog

Poster Presentation - Influence of NECC (Nutrition and Exercise Center for Cancer Patients) on survival and body composition in Gastrointestinal Cancer Patients

Abstract BACKGROUND : Gastrointestinal cancer patients are particularly predisposed to develop cancer cachexia. Cachectic patients are characterized by loss of adipose tissue as well as skeletal muscle wasting which has a tremendous impact on quality of life and survival (1, 4). In terms of improvement for this multifactorial syndrome, Klinikum rechts der Isar (MRI) in Munich, Germany has founded NECC, a treatment concept including nutrition intervention and an individual training program. METHODS : In this study we focused on patients with pancreatic (n =15) and upper gastrointestinal cancer (n = 21). Body composition using CT images was analyzed initially, 4 weeks, 3 months and 6 months after initial visit of NECC (Image 1). To underline the outcome, NECC patients were matched to adequate partners who correspond in age, gender, diagnosis with TNM classification and type of surgery. The control group does not receive any further support concerning nutrition and physical exercise
2 comments
Read more

Conference Venue

holiday Inn Rome - Aurelia,Via Aurelia Km, 8400 00165, Rome, Italy About City Rome is the capital city of Italy and Lazio region with 2,872,800 residents in 1,285 km2. It is the fourth most populous city in the European Union by population within city limits. Rome is located in central western Italian peninsulas. Rome has acquired the status of a global city. In 2016, Rome has been ranked as the 14th most visited cities in the world and 3rd most visited cities in Europe. It is a city that is proud of its ancient glorious heritage, a city that once expanded its empire throughout Europe, Africa and Asia. The city of Rome includes tourist places such as Colosseum, Pantheon, Spanish Steps, the Forum, Trevi Fountain, and the catacombs any of the buildings have arches, domes and vaults. Colosseum is one of the famous architecture symbols in Rome which is capable of housing 60,000 spectators and it is the largest amphitheater ever built in the Roman empire and it was used for gladia
2 comments
Read more

Poster Presentation - The Notch ligand DLL1 exerts pro-carcinogenic effects in human breast cancer luminal A MCF-7 cells

Abstract  Background: Breast cancer (BC) is the most common cancer in women and has a high rate of relapse and death. The Notch signaling pathway plays an important role in normal breast development and homeostasis. Dysregulation of Notch receptors and its ligands Jagged1, Jagged2, and DLL4 has been detected in BC and implicated in tumor development, progression, drug resistance, and recurrence. The Notch ligand DLL1 has emerged as a player in BC as its expression is undetectable in normal breast tissues, but moderate to high in BC. In this study, we examined the role of DLL1 in BC luminal A MCF-7 cells. Methodology: DLL1 siRNA and recombinant DLL1 protein were used to evaluate the effects of DLL1 in MCF-7 cells. Gene expression was analyzed by qRT-PCR and immunoblotting. Cell growth and proliferation were assessed by trypan blue exclusion and MTT methods. Microscopy and scratch wound-healing assays were used to evaluate colony formation and cell migration. Findings: In M
1 comment
Read more